Lobbying Filing Details

Total Spending

$410,000

Activities

3

Lobbyists

2

Gov't Entities

16

Filing Information
Filing UUID:
cfd44ef8-b8d5-43a8-8cc5-d4434af2911f
Type:
Q4 - 4th Quarter - Report
Period:
2025 - 4th Quarter (Oct 1 - Dec 31)
Date Posted:
January 20, 2026 at 6:50 PM
Income:
$0
Expenses:
$410,000
Expense Method:
A
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Valerie Jewett
Registrant
PHLOW CORPORATION

Generic Pharmaceutical Manufacturing

Richmond, Virginia
Client
PHLOW CORPORATION
Virginia, United States of America
Lobbying Activities (3)
Activity 1
Budget/Appropriations

FY26 Labor, Health and Human Services, Education, and Related Agencies Appropriations (H.R. 5304/S.2587); FY26 Department of Defense Appropriations (H.R. 4016/S.2572/S.2296/S.4638)

Lobbyists (2)
  • VALERIE HARDIN JEWETT
  • JOHN FUNDERBURK
Government Entities (6)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Office of Management & Budget (OMB)
  • Defense, Dept of (DOD)
  • Health & Human Services, Dept of (HHS)
  • ... and 1 more
Activity 2
Health Issues

Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act. (identical legislation)

Lobbyists (2)
  • VALERIE HARDIN JEWETT
  • JOHN FUNDERBURK
Government Entities (5)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Natl Security Council (NSC)
  • Defense, Dept of (DOD)
  • Health & Human Services, Dept of (HHS)
Activity 3
Manufacturing

Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act. (identical legislation)

Lobbyists (2)
  • VALERIE HARDIN JEWETT
  • JOHN FUNDERBURK
Government Entities (5)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Natl Security Council (NSC)
  • Defense, Dept of (DOD)
  • Health & Human Services, Dept of (HHS)

Source: LDA.gov, data retrieved November 9, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.